Equity Research Lab: - Nifty above 7850, Sensex steady; Oil & Gas up 1%

Three banks snapped up almost 90 percent of bonds sold by Indian states to foreigners, and turned them into derivatives, raising the prospect of more volatility in one of Asia's best performing debt markets.

Several market participants involved in the sale said offshore units of Nomura, Standard Chartered and Bank of America Merrill Lynch bought about 30 billion rupees (USD 451 million) of the 35 billion rupees on offer in October, the first window for foreigners to buy in.

Much of that debt was then sold for a hefty fee as derivatives known as total return swaps to offshore clients keen for the bonds' higher yields, compared with India's already popular sovereign debt, and with similar guarantees.

CDR plan: Lenders to infrastructure company Gammon Infra, are planning to invoke Strategic Debt Restructuring (SDR) to recover Rs 10,000 crore worth dues. Speaking to CNBC-TV18, Rakesh Sharma, managing director and chief executive officer, Canara Bank says the bank is examining various options to recover dues from the company and will await the Board's nod on the same. The bank has lent close to Rs 2000 crore to the infra company.

If you have any queries regarding the Nifty level and other market tips like Equity tips, stock cash tips, MCX trading tips, stock future tips call @ 8109999233 or fill form http://equityresearchlab.com/Freetrial.php

Share:

Read More

Equity Research Lab :- NIFTY Future: 7853 (+0.32%)

!!! Post a gap up opening, the Nifty traded in a tight range throughout the day. Heavyweights like ITC and HDFC Ltd witnessed some buying whereas weakness in Infosys and a few banking stocks kept the index under pressure. Nifty futures settled in a premium of 15 points. India VIX fell 5.1% to 17.0 !!!!!

Nifty Future R1: 7811 R2: 7770 R3: 7697

Pivot: 7843 S1: 7884 S2: 7916 S3: 7989

If you want to more information regarding the nifty future,Equity tips,stock cash tips,Commodity tips, Stock future tips, MCX trading tips call @ 8109999233 or fill form http://equityresearchlab.com/Freetrial.php

Share:

Read More

Equity Research Lab :- NIFTY Future: 7858 (+1.63%)

!!!!! Post a sharp sell-off on Wednesday, the Nifty saw decent buying the very next day. Apart from pharma, all sectors performed well leading the Nifty to end 111 points higher. Nifty futures settled in a premium of 16 points. India VIX fell 9.1% to 15.8 !!!!!

Nifty Future R1: 7896 R2: 7933 R3: 8033

Pivot: 7833 S1: 7796 S2: 7733 S3: 7633

If you want to more information regarding the Nifty future report and many other trading tips like Equity tips, stock cash tips,Commodity  tips, MCX trading tips,Stock future tips call@8109999233 or fill form http://equityresearchlab.com/Freetrial.php

Share:

Read More

Stock tips should be read before trading

Hi, there are certain things that are very reliable for making money from your investment. The entire share market trader must have to know about these Stock tips before doing trade.

The domestic markets witnessed a gap-up opening in trade on Thursday tracking positive trend seen in Asian markets and overnight gains on Wall Street as Federal minutes of the October 27-28 meeting signaled at high probability of December rate hike but a gradual tightening going ahead.
The S&P BSE Sensex rose as much as 187.5 points to reclaim its crucial level of 25,500, while the broader CNX Nifty was eying its key support level of 7,800.

Please see the other info in the link.

http://equityresearchlab.com/stock-tips.php

Share:

Read More

Equity Research Lab :- lOL Chemicals up 11%, raises Ibuprofen production capacity

Shares of lOL Chemicals and Pharmaceuticals climbed 11.2 percent intraday Thursday after the company successfully raised Ibuprofen manufacturing facility at its Ludhiana plant. "The company completed its de-bottlenecking/re-engineering project for its Ibuprofen manufacturing facilities at Barnala with project cost of Rs 24 crore and commenced the enhanced production from today," the APIs (active pharmaceutical ingredient) producer said in its filing. Post this completion, capacity of Ibuprofen plant increased to 6,200 tonne per annum. With this it becomes world's only largest backward integrated Ibuprofen producer with current installed capacity, manufacturing all intermediates stages and key starting materials at one location. The company says this facility approved by US Food & Drug Administration, ANVISA, EDQM, WHO and MOH Japan. It exports Ibuprofen in Europe, Latin America, Middle East and USA. At 11:27 hours IST, the scrip of IOL Chemicals and Pharmaceuticals was quoting at Rs 92.75, up Rs 7.70, or 9.05 percent on the BSE.

For more update of share market news and tips like Equity tips,MCX trading tips, Commodity tips, Stock cash tips, Stock Future tips and many other call @ 8109999233 or fill form http://equityresearchlab.com/Freetrial.php

Share:

Read More

Equity Research Lab :- NIFTY Future: 7732 (-1.54%)

!!!!! Post a flat start, the Nifty remained lackluster in the first half. However, sharp selling was seen in the second half, driving the index 110 points lower towards the end. India VIX rose 2.6% to 17.4 !!!!!!

Nifty Future R1: 7816 R2: 7901 R3: 8031

Pivot: 7771 S1: 7686 S2: 7641 S3: 7511

If you have more queries regarding the Nifty future, Equity tips, stock cash tips,Stock future tips, MCX trading tips, Commodity tips call @ 8109999233 or fill form  http://equityresearchlab.com/Freetrial.php our team will contact you as soon as possible.

Share:

Read More

Equity research Lab :- NIFTY Future: 7853 (+0.32%)

!!!!! Post a gap up opening, the Nifty traded in a tight range throughout the day. Heavyweights like ITC and HDFC Ltd witnessed some buying whereas weakness in Infosys and a few banking stocks kept the index under pressure. Nifty futures settled in a premium of 15 points. India VIX fell 5.1% to 17.0 !!!!!

Nifty Future R1: 7884 R2: 7916 R3: 7989

Pivot: 7843 S1: 7811 S2: 7770 S3: 7697

If you want to more information regarding the Stock future tips, stock cash tips,Commodity tips,MCX trading tips and many other call at@8109999233 or fill free trial form http://equityresearchlab.com/Freetrial.php
 

Share:

Read More